Tottori, David

Tottori, David was paid $726K by Medicaid between Jan 2018 and Mar 2020, across 12 billing codes. Its largest line is 95004, Percutaneous tests with allergenic extracts, immediate type reaction — 27% of everything it billed.

33Billing provider infoTOTTORI, DAVID
LAS VEGAS, NV 89104

33aNPI1245284546assigned 05/20/2006

33bProvider typeAllergy Physician

28Total paid$726K

24GClaims14,769

24DCodes billed12

24AFirst – last monthJan 2018 – Mar 2020

Compared with peers

Next to other Allergy Physician providers in Nevada

Rank by total paid#3 of 8

Median peer was paid$94K

This provider vs. median7.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	13,013	$704K
2019	1,553	$21K
2020	203	$2K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
95004	Percutaneous tests with allergenic extracts, immediate type reaction	27%	846	818	$197K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	19%	1,111	1,087	$136K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	16%	431	368	$115K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	16%	1,885	1,830	$114K
95117		6.9%	5,969	2,532	$50K
94010		6.3%	1,738	1,565	$46K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	4.0%	890	734	$29K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	3.9%	882	726	$28K
94060		1.1%	161	155	$8K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	161	157	$2K
J7612	Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg	<1%	51	47	$1.00
J2357	Injection, omalizumab, 5 mg	<1%	644	532	$0.48

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.